An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity

被引:1088
|
作者
Simopoulos, Artemis P. [1 ]
机构
[1] Ctr Genet Nutr & Hlth, 4330 Klingle St NW, Washington, DC 20016 USA
关键词
FTO (Fat Mass and Obesity-Associated) Gene; eicosanoids; omega-6 and omega-3 fatty acid ratio; omega-6 and omega-3 essential fatty acids; endocannabinoids; browning of adipose tissue; obesity; CARDIOVASCULAR-DISEASE RISK; LONG-CHAIN OMEGA-3; DIETARY FISH-OIL; LINOLENIC ACID; ARACHIDONIC-ACID; GENE-EXPRESSION; ADIPOSE-TISSUE; WEIGHT-LOSS; BODY-FAT; DOCOSAHEXAENOIC ACID;
D O I
10.3390/nu8030128
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
In the past three decades, total fat and saturated fat intake as a percentage of total calories has continuously decreased in Western diets, while the intake of omega-6 fatty acid increased and the omega-3 fatty acid decreased, resulting in a large increase in the omega-6/omega-3 ratio from 1:1 during evolution to 20:1 today or even higher. This change in the composition of fatty acids parallels a significant increase in the prevalence of overweight and obesity. Experimental studies have suggested that omega-6 and omega-3 fatty acids elicit divergent effects on body fat gain through mechanisms of adipogenesis, browning of adipose tissue, lipid homeostasis, brain-gut-adipose tissue axis, and most importantly systemic inflammation. Prospective studies clearly show an increase in the risk of obesity as the level of omega-6 fatty acids and the omega-6/omega-3 ratio increase in red blood cell (RBC) membrane phospholipids, whereas high omega-3 RBC membrane phospholipids decrease the risk of obesity. Recent studies in humans show that in addition to absolute amounts of omega-6 and omega-3 fatty acid intake, the omega-6/omega-3 ratio plays an important role in increasing the development of obesity via both AA eicosanoid metabolites and hyperactivity of the cannabinoid system, which can be reversed with increased intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). A balanced omega-6/omega-3 ratio is important for health and in the prevention and management of obesity.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Obesity: Fatty acids, omega-6/omega-3 ratio and inflammatory markers (vol 6, pg 77, 2005)
    Santos, R.
    Soares, A.
    Oliveira, B.
    Freitas, J.
    Macedo, M.
    Rebelo, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 663 - 663
  • [22] Omega-3 and omega-6 fatty acids: Inverse association with body fat percentage and obesity risk
    Yang, Zhen
    Lan, Yuejiao
    Yang, Kunpeng
    Zhang, Junzi
    Chen, Lin
    Meng, Tianli
    Wu, Mingda
    Lu, Xiaodan
    NUTRITION RESEARCH, 2025, 135 : 32 - 41
  • [23] The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases
    Simopoulos, Artemis P.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (06) : 674 - 688
  • [24] The Omega-6/Omega-3 Fatty Acid Ratio in Chronic Diseases: Animal Models and Molecular Aspects
    Kang, Jing X.
    HEALTHY AGRICULTURE, HEALTHY NUTRITION, HEALTHY PEOPLE, 2011, 102 : 22 - 29
  • [25] The omega-6/omega-3 ratio and cardiovascular disease risk: Uses and abuses
    Harris W.S.
    Current Cardiovascular Risk Reports, 2007, 1 (1) : 39 - 45
  • [26] Intake of omega-3 and omega-6 fatty acids and risk of ovarian cancer
    T. I. Ibiebele
    C. M. Nagle
    C. J. Bain
    P. M. Webb
    Cancer Causes & Control, 2012, 23 : 1775 - 1783
  • [27] Omega-6 and omega-3 fatty acid intake in Hungarian obese patients
    Halmy, Csaba
    Halmy, Laszlo
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S208 - S208
  • [28] Serum omega-3 and omega-6 fatty acid concentrations and natural fertility
    Stanhiser, Jamie
    Jukic, Anne Marie Z.
    Steiner, Anne Z.
    HUMAN REPRODUCTION, 2020, 35 (04) : 950 - 957
  • [29] Intake of omega-3 and omega-6 fatty acids and risk of ovarian cancer
    Ibiebele, T. I.
    Nagle, C. M.
    Bain, C. J.
    Webb, P. M.
    CANCER CAUSES & CONTROL, 2012, 23 (11) : 1775 - 1783
  • [30] Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders
    Thesing, Carisha S.
    Bot, Mariska
    Milaneschi, Yuri
    Giltay, Erik J.
    Penninx, Brenda W. J. H.
    PSYCHONEUROENDOCRINOLOGY, 2018, 87 : 53 - 62